Clinical Trials Directory

Trials / Completed

CompletedNCT05932225

Systane® Complete Preservative Free Lubricant Eye Drops

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance and safety of Systane Complete Preservative Free (PF) lubricant eye drops in subjects experiencing dry eye symptoms. Statistical analyses will be presented overall and by Dry Eye Disease (DED) group.

Detailed description

Subjects will participate in the study for approximately 30 days, with a Screening/Baseline visit scheduled on Day 1, a phone call scheduled on Day 15 ± 2 (Visit 2) and a follow-up visit scheduled on Day 30 ± 2 (Visit 3). Subjects will be asked to complete the Impact of Dry Eye on Everyday Life - Symptom Bother \[IDEEL-SB\]) questionnaire on Day 1 and Visit 3. In addition, subjects will be instructed to document Systane Complete PF dosing information on a daily basis using a subject diary.

Conditions

Interventions

TypeNameDescription
OTHERPropylene glycol solution/dropsCommercially available eye drops

Timeline

Start date
2023-08-18
Primary completion
2024-02-20
Completion
2024-02-20
First posted
2023-07-06
Last updated
2025-04-04
Results posted
2025-04-04

Locations

4 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05932225. Inclusion in this directory is not an endorsement.

Systane® Complete Preservative Free Lubricant Eye Drops (NCT05932225) · Clinical Trials Directory